Conversely, negative trials included more recent trials with lower mortality rates in the control arm 17-399%) [2, 3, 6].
Much has been learned from negative trials as to value of post hoc subgroup and interim analyses.
In the recombined negative trials, one shape outside of the memorized set was presented together with one of the colors in the set.
In the negative trials with the new irrelevant dimension, one shape outside of the set was presented in a color also outside the memorized set.
In the block of relevant color, three types of positive trials (intact, recombined, and new irrelevant) and two types of negative trials (recombined and new irrelevant) were performed.
In the negative trials, 18 with the repeated irrelevant dimension and 18 with a new irrelevant dimension were performed in each block.
Efforts to improve the assay sensitivity of analgesic trials could reduce the rate of falsely negative trials of efficacious medications and improve the efficiency of analgesic drug development.
Equivalently in the recombined negative trials, one color outside of the memorized set was presented with one of the shapes in the set; in the negative trials with the new irrelevant dimension, one color outside of the set was presented in a shape also outside of the set presented for memorization.
In the block in which shape was relevant, three types of positive trials (intact, recombined, and new irrelevant) and two types of negative trials (recombined and new irrelevant) were conducted.
If the test stimulus was present at the memorized set (positive trials), the participant should press the number 1 key, otherwise (negative trials) he should press the number two key.
The percentage of correct responses was analyzed using an ANOVA and considering load types (low and high) and five types of trials (intact, recombined, and new irrelevant in the positive trials, and recombined and new irrelevant in the negative trials).
